Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Breast cancer: origins and evolution
Kornelia Polyak
Kornelia Polyak
Published November 1, 2007
Citation Information: J Clin Invest. 2007;117(11):3155-3163. https://doi.org/10.1172/JCI33295.
View: Text | PDF
Science in Medicine

Breast cancer: origins and evolution

  • Text
  • PDF
Abstract

Breast cancer is not a single disease, but rather is composed of distinct subtypes associated with different clinical outcomes. Understanding this heterogeneity is key for the development of targeted cancer-preventative and -therapeutic interventions. Current models explaining inter- and intratumoral diversity are the cancer stem cell and the clonal evolution hypotheses. Although tumor initiation and progression are predominantly driven by acquired genetic alterations, recent data implicate a role for microenvironmental and epigenetic changes as well. Comprehensive unbiased studies of tumors and patient populations have significantly advanced our molecular understanding of breast cancer, but translating these findings into clinical practice remains a challenge.

Authors

Kornelia Polyak

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 Total
Citations: 9 26 23 30 17 19 12 18 19 16 12 14 17 17 16 19 12 2 298
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (298)

Title and authors Publication Year
An Investigation into Psychological Aspects of Patients Diagnosed with Breast Cancer: A Review Study of Postgraduate Theses Prepared in Turkey
Çıvgın U
European Journal of Breast Health 2025
Microbial molecules, metabolites, and malignancy
Thomas RM
Neoplasia (New York, N.Y.) 2025
Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer
Weddle CJ, Blancard M, Uche N, Pongpamorn P, Cejas RB, Burridge PW
NPJ Precision Oncology 2025
Gravitational forces and matrix stiffness modulate the invasiveness of breast cancer cells in bioprinted spheroids
Breideband L, Wächtershäuser KN, Sarkar R, Puspathasan M, Stelzer EH, Pampaloni F
Materials Today Bio 2025
A highly resolved integrated transcriptomic atlas of human breast cancers
Chen A, Kroehling L, Ennis CS, Denis GV, Monti S
bioRxiv 2025
Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action
Kim N, Lukong KE
Oncology Reviews 2025
Untangling Breast Cancer: Trailing Towards Nanoformulations-based Drug Development.
Verma R, Kumar K, Bhatt S, Yadav M, Kumar M, Tagde P, Rajinikanth PS, Tiwari A, Tiwari V, Nagpal D, Mittal V, Kaushik D
Recent patents on nanotechnology 2025
Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer
Hua Y, Duan N, Sun C, Yang F, Tian M, Sun Y, Zhao S, Gong J, Liu Q, Huang X, Liang Y, Fu Z, Li W, Yin Y
eLife 2025
Targeting WEE1 Kinase for Breast Cancer Therapeutics: An Update
Zhang Z, Harish R, Elahi N, Saini S, Telia A, Kundlas M, Koroleva A, Umoh IN, Lota M, Bilkhu M, Kawaiah A, Allala MR, Leukeu A, Nebuwa E, Sharifi N, Ashton AW, Jiao X, Pestell RG
International Journal of Molecular Sciences 2025
ZMYND8 Protects Breast Cancer Stem Cells against Oxidative Stress and Ferroptosis through Activation of NRF2
Maowu Luo, Lei Bao, Yuanyuan Xue, Ming Zhu, Ashwani Kumar, Chao Xing, Jennifer Wang, Yingfei Wang, Weibo Luo
Journal of Clinical Investigation 2024
Antidiabetic Drugs in Breast Cancer Patients
Garczorz W, Kosowska A, Francuz T
Cancers 2024
Catalysts of Healing: A Symphony of Synthesis and Clinical Artistry in Small-Molecule Agents for Breast Cancer Alleviation
Hu J, Zhu BY, Niu ZX
Molecules (Basel, Switzerland) 2024
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer
Zhou Y, Xue W, Meng X, Bhandari A, Zeng H, KC R, Hirachan S, Xia E
Breast cancer : targets and therapy 2024
Clinical significance of low expression of CADM3 in breast cancer and preliminary exploration of related mechanisms
Ren H, Wang Z, Zhang L, Zhu G, Li F, Chen B
BMC Cancer 2024
Functions of Differentially Regulated miRNAs in Breast Cancer Progression: Potential Markers for Early Detection and Candidates for Therapy
Subramanian K, Sinha R
Biomedicines 2024
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.
Wang J, Li B, Luo M, Huang J, Zhang K, Zheng S, Zhang S, Zhou J
Signal Transduction and Targeted Therapy 2024
MiR-103a-3p Promotes Tumorigenesis of Breast Cancer by Targeting ETNK1
Li L, Qiu A, Shi Y
Iranian journal of public health 2024
Breast cancer therapy: from the perspective of glucose metabolism and glycosylation.
Zhao J, Sun H, Wang C, Shang D
Molecular Biology Reports 2024
Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer
Liu X, Wang W, Chen B, Wang S
Aging 2024
A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response
Xu L, Saunders K, Huang SP, Knutsdottir H, Martinez-Algarin K, Terrazas I, Chen K, McArthur HM, Maués J, Hodgdon C, Reddy SM, Roussos Torres ET, Xu L, Chan IS
Cell reports. Medicine 2024
High expression of CCNB2 is an independent predictive poor prognostic biomarker and correlates with immune infiltrates in breast carcinoma
Lu Z, Wang Z, Li G
Heliyon 2024
NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m5C methylation
Zhang X, An K, Ge X, Sun Y, Wei J, Ren W, Wang H, Wang Y, Du Y, He L, Li O, Zhou S, Shi Y, Ren T, Yang YG, Kan Q, Tian X
Breast Cancer Research 2024
Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients
Malik S, Waquar S, Idrees N, Malik A
Scientific Reports 2024
Glycosylation: mechanisms, biological functions and clinical implications.
He M, Zhou X, Wang X
Signal Transduction and Targeted Therapy 2024
Lectins as a promising therapeutic agent for breast cancer: A review.
Singh K, Agrawal L, Gupta R, Singh D, Kathpalia M, Kaur N
Breast disease 2024
Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor.
Hasanlu M, Amiri-Dashatan N, Farahani M, Koushki M, Ahmadi H, Parsamanesh N, Ahmadi NA
Asian Pacific Journal of Cancer Prevention 2024
Association of Inflammation and Immune Cell Infiltration with Estrogen Receptor Alpha in an Estrogen and Ionizing Radiation-Induced Breast Cancer Model
Koning T, Calaf GM
International Journal of Molecular Sciences 2024
Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era.
Xiong X, Wang X, Liu CC, Shao ZM, Yu KD
Biomarker research 2024
Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review
Kunachowicz D, Kłosowska K, Sobczak N, Kepinska M
Nanomaterials 2024
Three-dimensional breast cancer tumor models based on natural hydrogels: a review
Journal of Zhejiang University. Science. B 2024
Micro-RNAs in breast cancer progression and metastasis: A chromatin and metabolic perspective.
Sikder S, Bhattacharya A, Agrawal A, Sethi G, Kundu TK
Heliyon 2024
Remote-Controlled Gene Delivery in Coaxial 3D-Bioprinted Constructs using Ultrasound-Responsive Bioinks
Lowrey MK, Day H, Schilling KJ, Huynh KT, Franca CM, Schutt CE
Cellular and Molecular Bioengineering 2024
CircRNAs and miRNAs: Key Player Duo in Breast Cancer Dynamics and Biomarkers for Breast Cancer Early Detection and Prevention
Maatouk N, Kurdi A, Marei S, Nasr R, Talhouk R
International Journal of Molecular Sciences 2024
Discordance in biomarker expression between primary breast cancers and loco-regional recurrences: a comprehensive analysis of 112 cases
Ma M, Chen X, Zhang Z, Zhao D, Zhao J, Sun Q, Mao F, Peng L
Gland Surgery 2024
Spices and culinary herbs for the prevention and treatment of breast cancer: A comprehensive review with mechanistic insights
Ali ML, Noushin F, Sadia QA, Metu AF, Meem JN, Chowdhury MT, Rasel MH, Suma KJ, Alim MA, Jalil MA, Mamun MJ, Hasan MM, Hoque N, Azme E
Cancer Pathogenesis and Therapy 2024
Intercellular HIF1a reprogams mammary progenitors and myeloid immune evasion to drive high-risk breast lesions
Irene Bertolini, Michela Perego, Yulia Nefedova, Cindy Lin, Andrew T Milcarek, Peter Vogel, Jagadish Ghosh, Andrew Kossenkov, Dario Altieri
Journal of Clinical Investigation 2023
FOXO3 gene hypermethylation and its marked downregulation in breast cancer cases: A study on female patients
Khan MA, Sadaf, Ahmad I, Aloliqi AA, Eisa AA, Najm MZ, Habib M, Mustafa S, Massey S, Malik Z, Sunita K, Pawar JS, Akhter N, Shukla NK, Deo SV, Husain SA
Frontiers in Oncology 2023
Evaluation of Lee–Carter model to breast cancer mortality prediction in China and Pakistan
Mubarik S, Wang F, Luo L, Hezam K, Yu C
Frontiers in Oncology 2023
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies
Melaiu O, Vanni G, Portarena I, Pistolese CA, Anemona L, Pomella S, Bei R, Buonomo OC, Roselli M, Mauriello A, Barillari G
International journal of molecular sciences 2023
Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors
Sammarco A, Gomiero C, Beffagna G, Cavicchioli L, Ferro S, Michieletto S, Orvieto E, Patruno M, Zappulli V
2023
Construction of a fatty acid metabolism-related gene signature for predicting prognosis and immune response in breast cancer
Qian L, Liu YF, Lu SM, Yang JJ, Miao HJ, He X, Huang H, Zhang JG
Frontiers in Genetics 2023
Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance
Butti R, Khaladkar A, Bhardwaj P, Prakasam G
2023
Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer.
Li J
BMC Cancer 2023
Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
Khan Y, Khan NU, Ali I, Khan S, Khan AU, Iqbal A, Adams BD
Molecular Biology Reports 2023
ForestSubtype: a cancer subtype identifying approach based on high-dimensional genomic data and a parallel random forest
Luo J, Feng Y, Wu X, Li R, Shi J, Chang W, Wang J
BMC bioinformatics 2023
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Srivastava N, Usmani SS, Subbarayan R, Saini R, Pandey PK
Frontiers in Oncology 2023
Deep learning model for predicting the presence of stromal invasion of breast cancer on digital breast tomosynthesis.
Shimokawa D, Takahashi K, Oba K, Takaya E, Usuzaki T, Kadowaki M, Kawaguchi K, Adachi M, Kaneno T, Fukuda T, Yagishita K, Tsunoda H, Ueda T
Radiological Physics and Technology 2023
Novel Method to Obtain Contact Angles of Tumor Biopsies.
Rincon J, Kastellorizios M
ACS Omega 2023
Rapid assessment of 3-dimensional intra-tumor heterogeneity through cycling temperature capillary electrophoresis
Połeć A, Ekstrøm PO, Fougner C, Sørlie T, Norum JH
BMC Research Notes 2023
Hypoxia-driven ncRNAs in breast cancer
H. Al-Zuaini H, Rafiq Zahid K, Xiao X, Raza U, Huang Q, Zeng T
Frontiers in Oncology 2023
Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
Hasan AK, Babaei E, Al-Khafaji AS
Journal of Advanced Pharmaceutical Technology & Research 2023
The EstroGene database reveals diverse temporal, context-dependent, and bidirectional estrogen receptor regulomes in breast cancer
Li Z, Li T, Yates ME, Wu Y, Ferber A, Chen L, Brown DD, Carroll JS, Sikora MJ, Tseng GC, Oesterreich S, Lee AV
Cancer research 2023
Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer
Ma R, Guan X, Teng N, Du Y, Ou S, Li X
BMC Medical Genomics 2023
Decoding Hidden Messengers: Proteomic Profiling of Exosomes in Mammary Cancer Research.
Novais AA, Tamarindo GH, Chuffa LGA, Zuccari DAPC
Biomedicines 2023
Patient Graph Deep Learning to Predict Breast Cancer Molecular Subtype
Furtney I, Bradley R, Kabuka MR
IEEE/ACM Transactions on Computational Biology and Bioinformatics 2023
Apocrine carcinoma-and-malignant myoepithelioma in a dog: a case of simultaneous malignant progression of both luminal epithelium and myoepithelium
Matsumoto K, Kishimoto TE, Yamamoto M, Michishita M, Takahashi K, Yoshimura H
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2023
Antiproliferative Modulation and Pro-Apoptotic Effect of BR2 Tumor-Penetrating Peptide Formulation 2-Aminoethyl Dihydrogen Phosphate in Triple-Negative Breast Cancer
Cabral LG, Oliveira CS, Freire KA, Alves MG, Oliveira VX, Poyet JL, Maria DA
Cancers 2023
Study of hesperetin effect on modulating transcription levels of MLH1 and MSH2 genes in SKBR3 breast cancer cell line
Saleh NH, Al-Khafaji AS, Babaei E
Journal of Advanced Pharmaceutical Technology & Research 2023
Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer
N Thang, S Yoo, H La, H Lee, C Park, K Park, K Hong
Biomedicines 2022
Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches
N Ayoub, S Jaradat, K Al-Shami, A Alkhalifa
Frontiers in pharmacology 2022
The Role of Extracellular Matrix Proteins in Breast Cancer
A Lepucki, K Orlińska, A Mielczarek-Palacz, J Kabut, P Olczyk, K Komosińska-Vassev
Journal of Clinical Medicine 2022
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay
Cipriani C, Pacheco MP, Kishk A, Wachich M, Abankwa D, Schaffner-Reckinger E, Sauter T
Pharmaceuticals 2022
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis
Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M, Bonavida B
Antioxidants 2022
Cold Atmospheric Plasma Attenuates Breast Cancer Cell Growth Through Regulation of Cell Microenvironment Effectors.
Aggelopoulos CA, Christodoulou AM, Tachliabouri M, Meropoulis S, Christopoulou ME, Karalis TT, Chatzopoulos A, Skandalis SS
Frontiers in Oncology 2022
Prognostic Value of Stromal Type IV Collagen Expression in Small Invasive Breast Cancers
Jansson M, Lindberg J, Rask G, Svensson J, Billing O, Nazemroaya A, Berglund A, Wärnberg F, Sund M
Frontiers in Molecular Biosciences 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation.
Li Z, McGinn O, Wu Y, Bahreini A, Priedigkeit NM, Ding K, Onkar S, Lampenfeld C, Sartorius CA, Miller L, Rosenzweig M, Cohen O, Wagle N, Richer JK, Muller WJ, Buluwela L, Ali S, Bruno TC, Vignali DAA, Fang Y, Zhu L, Tseng GC, Gertz J, Atkinson JM, Lee AV, Oesterreich S
Nature Communications 2022
Breast cancer in the era of integrating “Omics” approaches
Rossi C, Cicalini I, Cufaro MC, Consalvo A, Upadhyaya P, Sala G, Antonucci I, Del Boccio P, Stuppia L, De Laurenzi V
Oncogenesis 2022
Interrelated Oncogenic Viruses and Breast Cancer.
Afzal S, Fiaz K, Noor A, Sindhu AS, Hanif A, Bibi A, Asad M, Nawaz S, Zafar S, Ayub S, Hasnain SB, Shahid M
Frontiers in Molecular Biosciences 2022
Reduction on Proinflammatory Cytokines after Application of Transcutaneous Electrical Nerve Stimulation (TENS) in Patients with a Breast Cancer: A Nonrandomized, Open, and Single-Arm Study Protocol with Paired Analysis
do Carmo Almeida TC, Zatta SM, da Silva Paiva L, de Carvalho LE, Schoueri J, de Abreu LC, Fonseca FL, Adami F
Mediators of Inflammation 2022
miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer
Msheik ZS, Nassar FJ, Chamandi G, Itani AR, Gadaleta E, Chalala C, Alwan N, Nasr RR
Diagnostics 2022
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature.
Kohler KT, Goldhammer N, Demharter S, Pfisterer U, Khodosevich K, Rønnov-Jessen L, Petersen OW, Villadsen R, Kim J
npj Breast Cancer 2022
Potential of chimeric antigen receptor (CAR)‐redirected immune cells in breast cancer therapies: Recent advances
Nikoo M, Rudiansyah M, Bokov DO, Jainakbaev NT, Suksatan W, Ansari MJ, Thangavelu L, Chupradit S, Zamani A, Adili A, Shomali N, Akbari M
Journal of Cellular and Molecular Medicine 2022
Dietary phytochemicals/nutrients as promising protector of breast cancer development: a comprehensive analysis.
Samanta SK, Choudhury P, Sarma PP, Gogoi B, Gogoi N, Devi R
Pharmacological reports : PR 2022
LncRNAs in breast cancer: a link to future approaches.
Sideris N, Dama P, Bayraktar S, Stiff T, Castellano L
Cancer Gene Therapy 2022
ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells.
Luo M, Bao L, Chen Y, Xue Y, Wang Y, Zhang B, Wang C, Corley CD, McDonald JG, Kumar A, Xing C, Fang Y, Nelson ER, Wang JE, Wang Y, Luo W
Science Advances 2022
Analysis of the Effect of SNAI Family in Breast Cancer and Immune Cell.
Tu Y, Fang P, Zhang L, Sun K
Frontiers in Cell and Developmental Biology 2022
The potential of gas plasma technology for targeting breast cancer.
Bekeschus S, Saadati F, Emmert S
Clinical and Translational Medicine 2022
A Simultaneous Multiparametric 18F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer
Romeo V, Kapetas P, Clauser P, Baltzer PA, Rasul S, Gibbs P, Hacker M, Woitek R, Pinker K, Helbich TH
Cancers 2022
FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer
Zhang XX, Luo JH, Wu LQ
Frontiers in Genetics 2022
Fate decisions of breast cancer stem cells in cancer progression
Xu H, Zhang F, Gao X, Zhou Q, Zhu L
Frontiers in Oncology 2022
Comparison of dual mTORC1/2 inhibitor AZD8055 and mTORC1 inhibitor rapamycin on the metabolism of breast cancer cells using proton nuclear magnetic resonance spectroscopy metabolomics.
Ni Z, Xu S, Yu Z, Ye Z, Li R, Chen C, Yang J, Liu H, Zhou Z, Zhang X
Investigational New Drugs 2022
Systemic therapy for early-stage breast cancer: learning from the past to build the future
Agostinetto E, Gligorov J, Piccart M
Nature reviews. Clinical oncology 2022
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study.
Carlino F, Diana A, Ventriglia A, Piccolo A, Mocerino C, Riccardi F, Bilancia D, Giotta F, Antoniol G, Famiglietti V, Feliciano S, Cangiano R, Lobianco L, Pellegrino B, De Vita F, Ciardiello F, Orditura M
Cancers 2022
Chemotherapy-Induced Toxicities and Their Associations with Clinical and Non-Clinical Factors among Breast Cancer Patients in Vietnam.
Nguyen SM, Pham AT, Nguyen LM, Cai H, Tran TV, Shu XO, Tran HTT
Current oncology (Toronto, Ont.) 2022
Identification of immune cell function in breast cancer by integrating multiple single-cell data
Zhang L, Qin Q, Xu C, Zhang N, Zhao T
Frontiers in immunology 2022
Molecular Classification of Breast Carcinoma in a Tertiary Hospital of India: the Recent Trends
Siddiqui B, Ahmed S, Sinha D, Sharma AV
Indian Journal of Surgical Oncology 2022
Outcomes in patients with non‐invasive breast carcinoma
Kim R, Kawai A, Wakisaka M, Shimoyama M, Yasuda N, Ito M, Kin T, Arihiro K
EMBO reports 2022
Association of fruit, vegetable and animal food intakes with breast cancer risk overall and by molecular subtype among Vietnamese women
Nguyen SM, Tran HT, Nguyen LM, Bui O, Hoang D, Shrubsole MJ, Cai Q, Ye F, Zheng W, Luu HN, Tran TV, Shu XO
Cancer epidemiology, biomarkers & prevention 2022
Tumor Microenvironment: Novel Concepts
A Birbrair
2021
A new immunochemical strategy for triple-negative breast cancer therapy
CW Lin, T Zheng, G Grande, AR Nanna, C Rader, RA Lerner
Scientific Reports 2021
Role of estrogen receptor coregulators in endocrine resistant breast cancer
KA Altwegg, RK Vadlamudi
2021
Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification
Z Liu, J Liu, R Liu, M Xue, W Zhang, X Zhao, J Zhu, P Xia
BMC Cancer 2021
The Prolactin Inducible Protein Modulates Antitumor Immune Responses and Metastasis in a Mouse Model of Triple Negative Breast Cancer
CA Edechi, NM Ikeogu, GN Akaluka, LE Terceiro, M Machado, ES Salako, AF Barazandeh, SK Kung, JE Uzonna, Y Myal
Frontiers in Oncology 2021
Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer
A Novillo, A Fernández-Santander, M Gaibar, M Galán, A Romero-Lorca, FE Abdellaoui-Soussi, PG Arco
Frontiers in Oncology 2021
Novel lncRNAs Co-Expression Networks Identifies LINC00504 with Oncogenic Role in Luminal A Breast Cancer Cells
C Mathias, CS Groeneveld, S Trefflich, EP Zambalde, RS Lima, CA Urban, KB Prado, EM Ribeiro, MA Castro, DF Gradia, JC de Oliveira
International journal of molecular sciences 2021
Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression
R Butti, R Nimma, G Kundu, A Bulbule, TV Kumar, VP Gunasekaran, D Tomar, D Kumar, A Mane, SS Gill, T Patil, GF Weber, GC Kundu
Oncogene 2021
Single cell RNA sequencing for breast cancer: present and future
L Ren, J Li, C Wang, Z Lou, S Gao, L Zhao, S Wang, A Chaulagain, M Zhang, X Li, J Tang
Cell Death Discovery 2021
Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data
Y Hua, L Gao, X Li
Pathology oncology research : POR 2021
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer
R Chitalia, V Viswanath, AR Pantel, LM Peterson, A Gastounioti, EA Cohen, M Muzi, J Karp, DA Mankoff, D Kontos
European Journal of Nuclear Medicine and Molecular Imaging 2021
Breast cancer cell line toxicity of a flavonoid isolated from Baccharis densiflora
WS Sotillo, S Tarqui, X Huang, G Almanza, S Oredsson
2021
Breast tumor-on-chip models: From disease modeling to personalized drug screening
B Subia, UR Dahiya, S Mishra, J Ayache, GV Casquillas, D Caballero, RL Reis, SC Kundu
Journal of Controlled Release 2021
miR-183-5p Aggravates Breast Cancer Development via Mediation of RGS2
C Wu, Y Tuo, G Hu, J Luo, T Huang
Computational and mathematical methods in medicine 2021
Predicting master transcription factors from pan-cancer expression data
J Reddy, MA Fonseca, RI Corona, R Nameki, FS Dezem, IA Klein, H Chang, D Chaves-Moreira, LK Afeyan, TM Malta, X Lin, F Abbasi, A Font-Tello, T Sabedot, P Cejas, N Rodríguez-Malavé, JH Seo, DC Lin, U Matulonis, BY Karlan, SA Gayther, B Pasaniuc, A Gusev, H Noushmehr, H Long, ML Freedman, R Drapkin, RA Young, BJ Abraham, K Lawrenson
Science Advances 2021
Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review
Y Ye, C Xu, F Chen, Q Liu, N Cheng
Frontiers in immunology 2021
Heterogeneity of Circulating Tumor Cell–Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response
Kanwar N, Balde Z, Nair R, Dawe M, Chen S, Maganti M, Atenafu EG, Manolescu S, Wei C, Mao A, Fu F, Wang D, Cheung A, Yerofeyeva Y, Peters R, Liu K, Desmedt C, Sotiriou C, Szekely B, Kulka J, McKee TD, Hirano N, Bartlett JM, Yaffe MJ, Bedard PL, McCready D, Done SJ
Cancer research 2021
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
L Walcher, AK Kistenmacher, H Suo, R Kitte, S Dluczek, A Strauß, AR Blaudszun, T Yevsa, S Fricke, U Kossatz-Boehlert
Frontiers in immunology 2020
Tracing of Human Tumor Cell Lineages by Mitochondrial Mutations
P Refinetti, S Morgenthaler, WG Thilly, C Arstad, PO Ekstrøm
Frontiers in Oncology 2020
Microfluidic lumen-based systems for advancing tubular organ modeling
M Virumbrales-Muñoz, JM Ayuso, MM Gong, M Humayun, MK Livingston, KM Lugo-Cintrón, P McMinn, YR Álvarez-García, DJ Beebe
Chemical Society Reviews 2020
Secondary Metabolites from the Culture of the Marine-derived Fungus Paradendryphiella salina PC 362H and Evaluation of the Anticancer Activity of Its Metabolite Hyalodendrin
A Dezaire, CH Marchand, M Vallet, N Ferrand, S Chaouch, E Mouray, AK Larsen, M Sabbah, SD Lemaire, S Prado, AE Escargueil
Marine drugs 2020
A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer
A Demircioglu, J Grueneisen, M Ingenwerth, O Hoffmann, K Pinker-Domenig, E Morris, J Haubold, M Forsting, F Nensa, L Umutlu, PA Baltzer
PloS one 2020
A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis
Q Zhang, X Jin, W Shi, X Chen, W Pang, X Yu, L Yang
Cancer Cell International 2020
Prevalence and Type Distribution of High-Risk Human Papillomavirus (HPV) in Breast Cancer: A Qatar Based Study
G Sher, NA Salman, M Kulinski, RA Fadel, VK Gupta, A Anand, S Gehani, S Abayazeed, O Al-Yahri, F Shahid, S Alshaibani, S Hassan, MZ Chawdhery, G Davies, S Dermime, S Uddin, GH Ashrafi, K Junejo
Cancers 2020
Viroimmunotherapy for breast cancer: promises, problems and future directions
S Chaurasiya, Y Fong
Cancer Gene Therapy 2020
Embryonic Barcoding of Equipotent Mammary Progenitors Functionally Identifies Breast Cancer Drivers
Z Ying, S Beronja
Cell Stem Cell 2020
Therapeutic Potential of the Natural Compound S-Adenosylmethionine as a Chemoprotective Synergistic Agent in Breast, and Head and Neck Cancer Treatment: Current Status of Research
L Mosca, F Vitiello, A Coppola, L Borzacchiello, CP Ilisso, M Pagano, M Caraglia, G Cacciapuoti, M Porcelli
International journal of molecular sciences 2020
BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27
J He, M Wu, L Xiong, Y Gong, R Yu, W Peng, L Li, L Li, S Tian, Y Wang, Q Tao, T Xiang
Clinical Epigenetics 2020
Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1
L Xia, F Li, J Qiu, Z Feng, Z Xu, Z Chen, J Sun
BMC Cancer 2020
ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes
M Cassandri, A Butera, I Amelio, AM Lena, M Montanaro, A Mauriello, L Anemona, E Candi, RA Knight, M Agostini, G Melino
Oncogene 2020
Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1
M Fan, J Chen, J Gao, W Xue, Y Wang, W Li, L Zhou, X Li, C Jiang, Y Sun, X Wu, X Wu, H Ge, Y Shen, Q Xu
Cell Death and Disease 2020
Single-cell transcriptional diversity is a hallmark of developmental potential
GS Gulati, SS Sikandar, DJ Wesche, A Manjunath, A Bharadwaj, MJ Berger, F Ilagan, AH Kuo, RW Hsieh, S Cai, M Zabala, FA Scheeren, NA Lobo, D Qian, FB Yu, FM Dirbas, MF Clarke, AM Newman
Science 2020
Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib
Y Yu, H Liao, R Xie, Y Zhang, R Zheng, J Chen, B Zhang
Frontiers in Oncology 2020
Elemental bioimaging shows mercury and other toxic metals in normal breast tissue and in breast cancers
R Pamphlett, L Satgunaseelan, SK Jew, PA Doble, DP Bishop, Y Hu
PloS one 2020
Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
S Taurin, H Alkhalifa
Neoplasia (New York, N.Y.) 2020
Human papilloma virus (HPV) profiles in breast cancer: future management
S Islam, B Chakraborty, CK Panda
Annals of translational medicine 2020
Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem
JM Smigiel, SE Taylor, BL Bryson, I Tamagno, K Polak, MW Jackson
Journal of Cancer Metastasis and Treatment 2019
Single Cell Omics of Breast Cancer: An Update on Characterization and Diagnosis
S Dwivedi, P Purohit, R Misra, M Lingeswaran, JR Vishnoi, P Pareek, S Misra, P Sharma
Indian Journal of Clinical Biochemistry 2019
Methylation Changes of Primary Tumors, Monolayer, and Spheroid Tissue Culture Environments in Malignant Melanoma and Breast Carcinoma
ÖŞ Erdoğan, SK Erciyas, A Bilir, ŞB Tunçer, DA Ödemiş, S Kurul, H Karanlık, N Cabıoğlu, H Yazıcı
BioMed Research International 2019
Low expression of WWC1 , a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome
Z Wang, D Katsaros, N Biglia, Y Shen, Y Fu, M Tiirikainen, H Yu
FEBS Open Bio 2019
Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry
M Wu, Q Sun, CH Mo, JS Pang, JY Hou, LL Pang, HP Lu, YW Dang, SJ Fang, D Tang, G Chen, ZB Feng
Oncology reports 2019
Glycosylation and its implications in breast cancer
DA Scott, RR Drake
Expert Review of Proteomics 2019
Exploring specific prognostic biomarkers in triple-negative breast cancer
C Bao, Y Lu, J Chen, D Chen, W Lou, B Ding, L Xu, W Fan
Cell Death and Disease 2019
The Regulatory Role of MicroRNAs in Breast Cancer
HY Loh, BP Norman, KS Lai, NM Rahman, NB Alitheen, MA Osman
International journal of molecular sciences 2019
NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis
L Wan, T Liu, Z Hong, Y Pan, ST Sizemore, J Zhang, Z Ma
Breast Cancer Research 2019
Physical confinement induces malignant transformation in mammary epithelial cells
YC Lu, T Chu, MS Hall, DJ Fu, Q Shi, A Chiu, D An, LH Wang, Y Pardo, T Southard, CG Danko, J Liphardt, AY Nikitin, M Wu, C Fischbach, S Coonrod, M Ma
Biomaterials 2019
Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer
K Babaei, R Khaksar, T Zeinali, H Hemmati, A Bandegi, P Samidoust, MT Ashoobi, H Hashemian, K Delpasand, F Talebinasab, H Naebi, SH Mirpour, A Keymoradzadeh, SE Norollahi
BioMedicine 2019
Cancer overdiagnosis: a biological challenge and clinical dilemma
S Srivastava, E Koay, A Borowsky, A Marzo, S Ghosh, P Wagner, B Kramer
Nature Reviews Cancer 2019
Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells
S Li, J Zhou, H Wu, Q Lu, Y Tai, Q Liu, C Wang
Cell cycle (Georgetown, Tex.) 2018
Stromal cells in breast cancer as a potential therapeutic target
SS Dykes, VS Hughes, JM Wiggins, HO Fasanya, M Tanaka, D Siemann
Oncotarget 2018
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
P Roswall, M Bocci, M Bartoschek, H Li, G Kristiansen, S Jansson, S Lehn, J Sjölund, S Reid, C Larsson, P Eriksson, C Anderberg, E Cortez, LH Saal, C Orsmark-Pietras, E Cordero, BK Haller, J Häkkinen, IJ Burvenich, E Lim, A Orimo, M Höglund, L Rydén, H Moch, AM Scott, U Eriksson, K Pietras
Nature Medicine 2018
The Maxi-K (BK) Channel Antagonist Penitrem A as a Novel Breast Cancer-Targeted Therapeutic
A Goda, A Siddique, M Mohyeldin, N Ayoub, KE Sayed
Marine drugs 2018
Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines
AA Bakar, M Akhtar, NM Ali, S Yeap, C Quah, WS Loh, N Alitheen, S Zareen, Z Ul-Haq, S Shah
Molecules (Basel, Switzerland) 2018
Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence
VC Sinha, H Piwnica-Worms
Journal of Mammary Gland Biology and Neoplasia 2018
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Y Feng, M Spezia, S Huang, C Yuan, Z Zeng, L Zhang, X Ji, W Liu, B Huang, W Luo, B Liu, Y Lei, S Du, A Vuppalapati, HH Luu, RC Haydon, TC He, G Ren
Genes & Diseases 2018
Aberrant Promoter Methylation of YAP Gene and its Subsequent Downregulation in Indian Breast Cancer Patients
SA Real, F Parveen, AU Rehman, MA Khan, SV Deo, NK Shukla, SA Husain
BMC Cancer 2018
MicroRNAs in regulation of triple-negative breast cancer progression
D Piasecka, M Braun, R Kordek, R Sadej, H Romanska
Journal of Cancer Research and Clinical Oncology 2018
Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma
R Tamma, S Ruggieri, T Annese, G Simone, A Mangia, S Rega, FA Zito, B Nico, D Ribatti
Oncotarget 2018
Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?
S Zakhari, J Hoek
Cancers 2018
Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer
RS DeVaux, JI Herschkowitz
Journal of Mammary Gland Biology and Neoplasia 2018
The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast
H Villanueva, S Grimm, S Dhamne, K Rajapakshe, A Visbal, CM Davis, EA Ehli, SM Hartig, C Coarfa, DP Edwards
Journal of Mammary Gland Biology and Neoplasia 2018
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
G Yanovich, H Agmon, M Harel, A Sonnenblick, T Peretz, T Geiger
Cancer research 2018
Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity: HONG et al
D Hong, AJ Fritz, SK Zaidi, AJ van Wijnen, JA Nickerson, AN Imbalzano, JB Lian, JL Stein, GS Stein
Journal of Cellular Physiology 2018
Organotypic microfluidic breast cancer model reveals starvation-induced spatial-temporal metabolic adaptations
JM Ayuso, A Gillette, K Lugo-Cintrón, S Acevedo-Acevedo, I Gomez, M Morgan, T Heaster, KB Wisinski, SP Palecek, MC Skala, DJ Beebe
EBioMedicine 2018
Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases
QF Manson, WA Schrijver, ND ter Hoeve, CB Moelans, PJ van Diest
Clinical & Experimental Metastasis 2018
Fruit and vegetable consumption and breast cancer incidence: Repeated measures over 30 years of follow-up: Fruit and vegetable consumption and breast cancer
MS Farvid, WY Chen, BA Rosner, RM Tamimi, WC Willett, AH Eliassen
International Journal of Cancer 2018
Association of High Risk Human Papillomavirus and Breast cancer: A UK based Study
NA Salman, G Davies, F Majidy, F Shakir, H Akinrinade, D Perumal, GH Ashrafi
Scientific Reports 2017
ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
J Zhang, C Zhou, H Jiang, L Liang, W Shi, Q Zhang, P Sun, R Xiang, Y Wang, S Yang
Cell Death and Disease 2017
Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth
A Das, K Dhar, G Maity, S Sarkar, A Ghosh, I Haque, G Dhar, S Banerjee, SK Banerjee
Scientific Reports 2017
CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen
S Sarkar, A Ghosh, S Banerjee, G Maity, A Das, MA Larson, V Gupta, I Haque, O Tawfik, SK Banerjee
Oncogenesis 2017
Levels of MicroRNA Heterogeneity in Cancer Biology
N Petrovic, S Ergün, ER Isenovic
Molecular diagnosis & therapy 2017
VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
Y Zhang, H Shen, HG Withers, N Yang, KE Denson, AL Mussell, A Truskinovsky, Q Fan, IH Gelman, C Frangou, J Zhang
Scientific Reports 2017
Antitumoral effects of γCdcPLI, a PLA2 inhibitor from Crotalus durissus collilineatus via PI3K/Akt pathway on MDA-MB-231 breast cancer cell
SN Gimenes, DS Lopes, PT Alves, FV Azevedo, L Vecchi, LR Goulart, TC Rodrigues, AL Santos, VL de Brites, TL Teixeira, CV da Silva, MH Dias, SC Teixeira, RS Rodrigues, KA Yoneyama, RA Oliveira, VM Rodrigues
Scientific Reports 2017
Anti-cancer stem cell activity of a sesquiterpene lactone isolated from Ambrosia arborescens and of a synthetic derivative
WS Sotillo, R Villagomez, S Smiljanic, X Huang, A Malakpour, S Kempengren, G Rodrigo, G Almanza, O Sterner, S Oredsson, A Ahmad
PloS one 2017
Applying Multivariate Adaptive Splines to Identify Genes With Expressions Varying After Diagnosis in Microarray Experiments
F Duan, Y Xu
Cancer informatics 2017
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents
N Ayoub, K Al-Shami, MA Alqudah, N Mhaidat
OncoTargets and therapy 2017
In vivo validation of metastasis-regulating microRNA-766 in human triple-negative breast cancer cells
K Oh, DS Lee
Laboratory animal research 2017
Current Progresses of Single Cell DNA Sequencing in Breast Cancer Research
J Liu, R Adhav, X Xu
International journal of biological sciences 2017
The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment
NM Ayoub, AB Siddique, HY Ebrahim, MM Mohyeldin, KA el Sayed
European Journal of Pharmacology 2017
Serum atrial natriuretic peptide: a suspected biomarker of breast cancer
ME Houssen, HF Ghazy, K Farag, MA El-Hussiny, MA el Ghaffar, SA Alsayed, O Farouk
WSPOLCZESNA ONKOL 2017
Induction of Apoptosis in Human Breast Cancer MCF-7 Cells by a SemiSynthetic Derivative of Artemisinin: A Caspase-Related Mechanism
L Jamalzadeh, H Ghafoori, M Aghamaali, R Sariri
IRAN J BIOTECHNOL 2017
Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells
N Wang, Q Wang, H Tang, F Zhang, Y Zheng, S Wang, J Zhang, Z Wang, X Xie
Journal of Experimental & Clinical Cancer Research 2017
Risk Factors and Preventions of Breast Cancer
YS Sun, Z Zhao, ZN Yang, F Xu, HJ Lu, ZY Zhu, W Shi, J Jiang, PP Yao, HP Zhu
International journal of biological sciences 2017
Promoter Hypermethylation of the ATM Gene as a Novel Biomarker for Breast Cancer
Nasrin Begam, Kaiser Jamil, Suryanarayana G Raju
Asian Pacific Journal of Cancer Prevention 2017
Molecular Subtypes of Breast Cancers from Myanmar Women: A Study of 91 Cases at Two Pathology Centers
Thar Htet San, Masayoshi Fujisawa, Soichiro Fushimi, Lamin Soe, Ngu Wah Min, Teizo Yoshimura, Toshiaki Ohara, Myint Myint Yee, Shinsuke Oda, Akihiro Matsukawa
Asian Pacific Journal of Cancer Prevention 2017
The Growth Inhibitory Potential and Antimetastatic Effect of Camel Urine on Breast Cancer Cells In Vitro and In Vivo
F Romli, N Abu, FA Khorshid, SU Najmuddin, YS Keong, NE Mohamad, M Hamid, NB Alitheen, NM Rahman
Integrative Cancer Therapies 2016
Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model
AC Gregório, NA Fonseca, V Moura, M Lacerda, P Figueiredo, S Simões, S Dias, JN Moreira, LZ Sun
PloS one 2016
IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells
K Oh, OY Lee, Y Park, MW Seo, DS Lee
BMC Cancer 2016
Interobserver Variability of Ki-67 Measurement in Breast Cancer
YR Chung, MH Jang, SY Park, G Gong, WH Jung
Journal of Pathology and Translational Medcine 2016
miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development
N Petrović
Molecular diagnosis & therapy 2016
Molecular subtypes and imaging phenotypes of breast cancer
N Cho
Ultrasonography 2016
Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
L He, J Gu, LY Lim, Z Yuan, J Mo
Frontiers in pharmacology 2016
In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium
JC Alfonso, NS Schaadt, R Schönmeyer, N Brieu, G Forestier, C Wemmert, F Feuerhake, H Hatzikirou
Scientific Reports 2016
The association of PTEN hypermethylation and breast cancer: a meta-analysis
S Luo, J Chen, X Mo
OncoTargets and therapy 2016
Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model
J Chapa, G An, SA Kulkarni, W Xu
PloS one 2016
MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer
CW Chang, JC Yu, YH Hsieh, CC Yao, JI Chao, PM Chen, HY Hsieh, CN Hsiung, HW Chu, CY Shen, CW Cheng
Oncotarget 2016
‘Normalizing’ the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin
H Abu-Tayeh, K Weidenfeld, A Zhilin-Roth, S Schif-Zuck, S Thaler, C Cotarelo, TZ Tan, JP Thiery, JE Green, G Klorin, E Sabo, JP Sleeman, M Tzukerman, D Barkan
Cell Death and Disease 2016
Learning From Mistakes: Importance of a Multidisciplinary Group, A Case Report
D Pezzulla, C Scoglio, R Capasso, F Cioce, A Sica, S Cappabianca
World Journal of Oncology 2016
DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
T Fleischer, J Klajic, MR Aure, R Louhimo, AV Pladsen, L Ottestad, N Touleimat, M Laakso, AR Halvorsen, GI Alnæs, ML Riis, Å Helland, S Hautaniemi, PE Lønning, B Naume, AL Børresen-Dale, J Tost, VN Kristensen
Oncotarget 2016
ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion
TT Dang, JM Westcott, EA Maine, M Kanchwala, C Xing, GW Pearson
Oncotarget 2016
Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women
Ling H, Li S, Wu Y, Zheng YZ, Qiao F, Yao L, Cao ZG, Ye FG, Wu J, Hu X, Wang B, Shao ZM
Oncotarget 2016
The interplay of extracellular matrix and microbiome in urothelial bladder cancer
M Alfano, F Canducci, M Nebuloni, M Clementi, F Montorsi, A Salonia
Nature Reviews Urology 2015
The origin of breast tumor heterogeneity
A Skibinski, C Kuperwasser
Oncogene 2015
Common 4977 bp deletion and novel alterations in mitochondrial DNA in Vietnamese patients with breast cancer
J Dimberg, TT Hong, LT Nguyen, M Skarstedt, S Löfgren, A Matussek
SpringerPlus 2015
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines
CP Ilisso, M Castellano, S Zappavigna, A Lombardi, G Vitale, A Dicitore, G Cacciapuoti, M Caraglia, M Porcelli
Endocrine 2015
May CTC technologies promote better cancer management?
M Pesta, V Kulda, A Narsanska, J Fichtl, O Topolcan
The EPMA Journal 2015
Clinical management of breast cancer heterogeneity
D Zardavas, A Irrthum, C Swanton, M Piccart
Nature Reviews Clinical Oncology 2015
Pathway-based Biomarkers for Breast Cancer in Proteomics
Zhang, Y Deng, L Cui, R Drabier, M Wang
Cancer informatics 2015
Selenium and Chronic Diseases: A Nutritional Genomics Perspective
C Méplan
Nutrients 2015
Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis
Z Wang, D Katsaros, Y Shen, Y Fu, EM Canuto, C Benedetto, L Lu, WM Chu, HA Risch, H Yu, WB Coleman
PloS one 2015
MicroRNA Regulation of Human Breast Cancer Stem Cells
Y Shimono, J Mukohyama, S Nakamura, H Minami
Journal of Clinical Medicine 2015
Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study
J Wang, F Kato, N Oyama-Manabe, R Li, Y Cui, KK Tha, H Yamashita, K Kudo, H Shirato, X Fan
PloS one 2015
Unique epigenetic gene profiles define human breast cancers with poor prognosis
S Peña-Llopis, Y Wan, ED Martinez
Oncotarget 2015
Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines
P Elumalai, AB Mercy, R Arunkamar, G Sharmila, FA Bhat, S Balakrishnan, PR Singh, J Arunakaran
Cell Proliferation 2014
Molecular Markers for Breast Cancer: Prediction on Tumor Behavior
BK Hirata, JM Oda, RL Guembarovski, CB Ariza, CE de Oliveira, MA Watanabe
Disease Markers 2014
The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors
DA Quigley, E Fiorito, S Nord, PV Loo, GG Alnæs, T Fleischer, J Tost, HK Vollan, T Tramm, J Overgaard, IR Bukholm, A Hurtado, A Balmain, AL Børresen-Dale, V Kristensen
Molecular Oncology 2014
Cellular Localization, Invasion, and Turnover Are Differently Influenced by Healthy and Tumor-Derived Extracellular Matrix
L Genovese, L Zawada, A Tosoni, A Ferri, P Zerbi, R Allevi, M Nebuloni, M Alfano
Tissue Engineering Part A 2014
Development of detection method for novel fusion gene using GeneChip exon array
Y Wada, M Matsuura, M Sugawara, M Ushijima, S Miyata, K Nagasaki, T Noda, Y Miki
Journal of Clinical Bioinformatics 2014
Metabolic implication of tumor:stroma crosstalk in breast cancer
A Morandi, P Chiarugi
Journal of Molecular Medicine 2014
Regulation of mammary epithelial cell homeostasis by lncRNAs
AN Shore, JM Rosen
The International Journal of Biochemistry & Cell Biology 2014
Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells
P Aumsuwan, SI Khan, IA Khan, B Avula, LA Walker, WG Helferich, BS Katzenellenbogen, AK Dasmahapatra
In vitro cellular & developmental biology. Animal 2014
Functional characterization of breast cancer using pathway profiles
F Tian, Y Wang, M Seiler, Z Hu
BMC Medical Genomics 2014
Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition
RK Kim, Y Suh, KC Yoo, YH Cui, E Hwang, HJ Kim, JS Kang, MJ Kim, YY Lee, SJ Lee
Cancer Science 2014
CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population
M Tsuchiya, Y Nakajima, T Waku, H Hiyoshi, T Morishita, R Furumai, Y Hayashi, H Kishimoto, K Kimura, J Yanagisawa
Oncogene 2014
Hepatoma upregulated protein expression is involved in the pathogenesis of human breast carcinogenesis
J Chen, QJ Liu, D Wang, XY Zhou, D Xiong, HJ Li, CL Li
Oncology Letters 2014
Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer
T Jiang, W Shi, R Natowicz, SN Ononye, VB Wali, Y Kluger, L Pusztai, C Hatzis
BMC Genomics 2014
Benign Breast Tissue Composition in Breast Cancer Patients: Association with Risk Factors, Clinical Variables, and Gene Expression
X Sun, R Sandhu, JD Figueroa, GL Gierach, ME Sherman, MA Troester
Cancer epidemiology, biomarkers & prevention 2014
Adiposity, inflammation, genetic variants and risk of post-menopausal breast cancer findings from a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design approach
XS Yan, J Barnholtz-Sloan, X Chu, L Li, R Colonie, J Webster, D Smelser, N Patel, J Prichard, A Stark
SpringerPlus 2013
A MicroRNA Component of the Neoplastic Microenvironment: Microregulators with Far-Reaching Impact
X Li, Z Wu, X Fu, W Han
BioMed Research International 2013
Recursive SVM biomarker selection for early detection of breast cancer in peripheral blood
F Zhang, HL Kaufman, Y Deng, R Drabier
BMC Medical Genomics 2013
Breast cancer subtyping from plasma proteins
F Zhang, JY Chen
BMC Medical Genomics 2013
Cancer, stem cell misplacement and cancer stem cells
Y Liao
Journal of Cellular and Molecular Medicine 2013
Benefits of multidisciplinary teamwork in the management of breast cancer
C Taylor, A Shewbridge, J Harris, JS Green
Breast cancer : targets and therapy 2013
Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer
F Zhang, M Wang, T Michael, R Drabier
BMC Systems Biology 2013
Multiple biomarker panels for early detection of breast cancer in peripheral blood
F Zhang, Y Deng, R Drabier
BioMed Research International 2013
Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer
D Lesniak, S Sabri, Y Xu, K Graham, P Bhatnagar, M Suresh, B Abdulkarim
PloS one 2013
Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: A novel epigenetic therapeutic approach
A Starlard-Davenport, K Kutanzi, V Tryndyak, B Word, B Lyn-Cook
Journal of carcinogenesis 2013
Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics
J Chapa, RJ Bourgo, GL Greene, S Kulkarni, G An
PloS one 2013
Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein
Y Li, H Chen, TM Hardy, TO Tollefsbol
PloS one 2013
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells
A Pincini, G Tornillo, F Orso, M Sciortino, B Bisaro, MP Leal, A Lembo, MF Brizzi, E Turco, CD Pittà, P Provero, E Medico, P Defilippi, D Taverna, S Cabodi
Cell cycle (Georgetown, Tex.) 2013
Molecular and Cellular Heterogeneity in Breast Cancer
AG Rivenbark, SM OConnor, WB Coleman
The American Journal of Pathology 2013
A neural network approach to multi-biomarker panel discovery by high-throughput plasma proteomics profiling of breast cancer
F Zhang, J Chen, M Wang, R Drabier
BMC proceedings 2013
Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer
Limame R, de Beeck KO, Van Laere S, Croes L, De Wilde A, Dirix L, Van Camp G, Peeters M, De Wever O, Lardon F, Pauwels P
Oncoscience 2013
Pituitary Tumor-Transforming Gene 1 Is Expressed in Primary Ductal Breast Carcinoma, Lymph Node Infiltration, and Distant Metastases
Grizzi F, Di Biccari S, Fiamengo B, Štifter S, Colombo P
Disease Markers 2013
Genome organizing function of SATB1 in tumor progression
T Kohwi-Shigematsu, K Poterlowicz, E Ordinario, HJ Han, VA Botchkarev, Y Kohwi
Seminars in Cancer Biology 2012
Multiscale Models of Breast Cancer Progression
A Chakrabarti, S Verbridge, AD Stroock, C Fischbach, JD Varner
Annals of Biomedical Engineering 2012
Role of ERRF, a Novel ER-Related Nuclear Factor, in the Growth Control of ER-Positive Human Breast Cancer Cells
D Su, X Fu, S Fan, X Wu, XX Wang, L Fu, XY Dong, JJ Ni, L Fu, Z Zhu, JT Dong
The American Journal of Pathology 2012
Active Roles of Tumor Stroma in Breast Cancer Metastasis
ZI Khamis, ZJ Sahab, QX Sang
International Journal of Breast Cancer 2012
BRCA1 – Conductor of the Breast Stem Cell Orchestra: The Role of BRCA1 in Mammary Gland Development and Identification of Cell of Origin of BRCA1 Mutant Breast Cancer
NE Buckley, PB Mullan
Stem Cell Reviews and Reports 2012
The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the “Seed” and the “Soil”?
JE Chu, AL Allan
International Journal of Breast Cancer 2012
DMSO exhibits similar cytotoxicity effects to thalidomide in mouse breast cancer cells
ES Oz, E Aydemir, K Fışkın
Oncology Letters 2012
Derivation of Myoepithelial Progenitor Cells from Bipotent Mammary Stem/Progenitor Cells
X Zhao, GK Malhotra, H Band, V Band
PloS one 2012
Arsenic Induces Functional Re-Expression of Estrogen Receptor α by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer
J Du, N Zhou, H Liu, F Jiang, Y Wang, C Hu, H Qi, C Zhong, X Wang, Z Li
PloS one 2012
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
NA Saunders, F Simpson, EW Thompson, MM Hill, L Endo-Munoz, G Leggatt, RF Minchin, A Guminski
EMBO Molecular Medicine 2012
Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines
S Chandrasekaran, Y Geng, LA DeLouise, MR King
Biomaterials 2012
The impact of the stromal cell-derived factor-1–3′A and E-selectin S128R polymorphisms on breast cancer
P Kontogianni, CP Zambirinis, G Theodoropoulos, M Gazouli, NV Michalopoulos, J Flessas, M Liberi, GC Zografos
Molecular Biology Reports 2012
Suppression of Wnt1-induced mammary tumor growth and lower serum insulin in offspring exposed to maternal blueberry diet suggest early dietary influence on developmental programming
OM Rahal, JM Pabona, T Kelly, Y Huang, LJ Hennings, RL Prior, A Al-Dwairi, FA Simmen, RC Simmen
Carcinogenesis 2012
The expression of Psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells
J Vegfors, S Petersson, A Kovács, K Polyak, C Enerbäck
PloS one 2012
ATM suppresses SATB1-induced malignant progression in breast epithelial cells
E Ordinario, HJ Han, S Furuta, LM Heiser, LR Jakkula, F Rodier, PT Spellman, J Campisi, JW Gray, MJ Bissell, Y Kohwi, T Kohwi-Shigematsu
PloS one 2012
A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications
M Marotta, X Chen, A Inoshita, R Stephens, GT Budd, JP Crowe, J Lyons, A Kondratova, R Tubbs, H Tanaka
Breast Cancer Research 2012
FGFR1 amplification and the progression of non-invasive to invasive breast cancer
AA Gru, DC Allred
Breast Cancer Research 2012
Insight into the Heterogeneity of Breast Cancer through Next-Generation Sequencing
Hege Russnes, Nicholas Navin, James Hicks, Anne-Lise Borresen-Dale
Journal of Clinical Investigation 2011
Heterogeneity in breast cancer
Kornelia Polyak
Journal of Clinical Investigation 2011
HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis
ZC Hartman, XY Yang, O Glass, G Lei, T Osada, SS Dave, MA Morse, TM Clay, HK Lyerly
Cancer research 2011
Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women
M Jing, X Mao, C Li, J Wei, C Liu, F Jin
Tumor Biology 2011
Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study
B Matković, A Juretić, GC Spagnoli, V Separović, M Gamulin, R Separović, N Sarić, M Basić-Koretić, I Novosel, B Kruslin
Croatian medical journal 2011
MicroRNA regulation in cancer-associated fibroblasts
O Aprelikova, JE Green
Cancer Immunology Immunotherapy 2011
Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study
Y Lian, M Sang, C Ding, X Zhou, X Fan, Y Xu, W Lü, B Shan
Journal of Cancer Research and Clinical Oncology 2011
Genome and Transcriptome Profiles of CD133-Positive Colorectal Cancer Cells
T Gaiser, J Camps, S Meinhardt, D Wangsa, QT Nguyen, S Varma, C Dittfeld, LA Kunz-Schughart, R Kemmerling, MR Becker, K Heselmeyer-Haddad, T Ried
The American Journal of Pathology 2011
The microenvironment in breast cancer progression: biology and implications for treatment
AE Place, SJ Huh, K Polyak
Breast Cancer Research 2011
Defining the cellular precursors to human breast cancer
PJ Keller, LM Arendt, A Skibinski, T Logvinenko, I Klebba, S Dong, AE Smith, A Prat, CM Perou, H Gilmore, S Schnitt, SP Naber, JA Garlick, C Kuperwasser
Proceedings of the National Academy of Sciences 2011
The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer
A Dhasarathy, D Phadke, D Mav, RR Shah, PA Wade
PloS one 2011
A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis
DY Wang, SJ Done, DR McCready, S Boerner, S Kulkarni, WL Leong
Breast Cancer Research 2011
Estrogen Up-regulates ATBF1 Transcription but Causes Its Protein Degradation in Estrogen Receptor-α-positive Breast Cancer Cells*
XY Dong, P Guo, X Sun, Q Li, JT Dong
The Journal of biological chemistry 2011
RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells
D Wang, J Huang, Z Hu
Molecular & cellular proteomics : MCP 2011
Aberrant promoter CpG methylation and its translational applications in breast cancer
TX Xiang, Y Yuan, LL Li, ZH Wang, LY Dan, Y Chen, GS Ren, Q Tao
Chinese journal of cancer 2011
Heterogeneity of breast cancer: etiology and clinical relevance
V Almendro, G Fuster
Clinical and Translational Oncology 2011
Claudin 1 in Breast Tumorigenesis: Revelation of a Possible Novel “Claudin High” Subset of Breast Cancers
Y Myal, E Leygue, AA Blanchard
Journal of Biomedicine and Biotechnology 2010
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion
X Jiao, S Katiyar, NE Willmarth, M Liu, X Ma, N Flomenberg, MP Lisanti, RG Pestell
The Journal of biological chemistry 2010
Genetic variegation of clonal architecture and propagating cells in leukaemia
K Anderson, C Lutz, FW van Delft, CM Bateman, Y Guo, SM Colman, H Kempski, AV Moorman, I Titley, J Swansbury, L Kearney, T Enver, M Greaves
Nature 2010
Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients
HG Russnes, HK Vollan, OC Lingjaerde, A Krasnitz, P Lundin, B Naume, T Sorlie, E Borgen, IH Rye, A Langerod, SF Chin, AE Teschendorff, PJ Stephens, S Maner, E Schlichting, LO Baumbusch, R Karesen, MP Stratton, M Wigler, C Caldas, A Zetterberg, J Hicks, AL Borresen-Dale
Science Translational Medicine 2010
Ductal Carcinoma In Situ: Terminology, Classification, and Natural History
DC Allred
JNCI Monographs 2010
Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression
AB Popławski, M Jankowski, SW Erickson, TD de Ståhl, EC Partridge, C Crasto, J Guo, J Gibson, U Menzel, CE Bruder, A Kaczmarczyk, M Benetkiewicz, R Andersson, J Sandgren, B Zegarska, D Bała, E Srutek, DB Allison, A Piotrowski, W Zegarski, JP Dumanski
European Journal of Human Genetics 2010
Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells
ME Montañez-Wiscovich, MD Shelton, DD Seachrist, KL Lozada, E Johnson, JD Miedler, FW Abdul-Karim, JE Visvader, RA Keri
The Journal of Pathology 2010
Molecular Markers for the Diagnosis and Management of Ductal Carcinoma In Situ
K Polyak
JNCI Monographs 2010
Tracing the tumor lineage
NE Navin, J Hicks
Molecular Oncology 2010
Stem cells in the human breast
OW Petersen, K Polyak
Cold Spring Harbor perspectives in biology 2010
Genomic instability in breast cancer: pathogenesis and clinical implications
KA Kwei, Y Kung, K Salari, IN Holcomb, JR Pollack
Molecular Oncology 2010
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer
SY Park, HE Lee, H Li, M Shipitsin, R Gelman, K Polyak
Clinical cancer research 2010
Septic disruption of lactiferous ducts with heterogeneous carcinoma of the breast in a lactating woman
M Naim, VT John, K Gaur, A Anees
BMJ case reports 2010
Of mice and women: A short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method
D Medina
Cold Spring Harbor perspectives in biology 2010
The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts
O Aprelikova, X Yu, J Palla, BR Wei, S John, M Yi, R Stephens, RM Simpson, JI Risinger, A Jazaeri, J Niederhuber
Cell cycle (Georgetown, Tex.) 2010
Triple-negative breast cancer: Present challenges and new perspectives
F Podo, LM Buydens, H Degani, R Hilhorst, E Klipp, IS Gribbestad, SV Huffel, HW van Laarhoven, J Luts, D Monleon, GJ Postma, N Schneiderhan-Marra, F Santoro, H Wouters, HG Russnes, T Sørlie, E Tagliabue, AL Børresen-Dale
Molecular Oncology 2010
Histological types of breast cancer: How special are they?
B Weigelt, FC Geyer, JS Reis-Filho
Molecular Oncology 2010
p53 nuclear accumulation and ERα expression in ductal hyperplasia of breast in a cohort of 215 Chinese women
X Mao, C Fan, H Zheng, J Wei, F Yao, F Jin
Journal of Experimental & Clinical Cancer Research 2010
Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression.
Hsiao YH, Su YA, Tsai HD, Mason JT, Chou MC, Man YG
International journal of biological sciences 2010
Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival
VP Pai, AM Marshall, LL Hernandez, AR Buckley, ND Horseman
Breast Cancer Research 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Tumor stroma derived biomarkers in cancer
M Sund, R Kalluri
Cancer and Metastasis Reviews 2009
Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor
KR Coser, BS Wittner, NF Rosenthal, SC Collins, A Melas, SL Smith, CJ Mahoney, K Shioda, KJ Isselbacher, S Ramaswamy, T Shioda
Proceedings of the National Academy of Sciences 2009
Genetic characterization of breast cancer and implications for clinical management
FC Geyer, MA Lopez-Garcia, MB Lambros, JS Reis-Filho
Journal of Cellular and Molecular Medicine 2009
Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats
A Starlard-Davenport, VP Tryndyak, SR James, AR Karpf, JR Latendresse, FA Beland, IP Pogribny
Carcinogenesis 2009
A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer
DA Kulkarni, A Vazquez, BG Haffty, EV Bandera, W Hu, YY Sun, DL Toppmeyer, AJ Levine, KM Hirshfield
Carcinogenesis 2009
Histological and molecular types of breast cancer: is there a unifying taxonomy?
B Weigelt, JS Reis-Filho
Nature Reviews Clinical Oncology 2009
Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin
LA Shevde, BJ Metge, A Mitra, Y Xi, J Ju, JA King, RS Samant
Journal of Cellular and Molecular Medicine 2009
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery
J Kao, K Salari, M Bocanegra, YL Choi, L Girard, J Gandhi, KA Kwei, T Hernandez-Boussard, P Wang, AF Gazdar, JD Minna, JR Pollack
PloS one 2009
Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression
C Williams, L Helguero, K Edvardsson, LA Haldosén, JA Gustafsson
Breast Cancer Research 2009
Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, Tamaki Y, Terada N, Noguchi S
Cancer Science 2009
Epigenomics and breast cancer
PK Lo, S Sukumar
Pharmacogenomics 2008
Two-dimensional electrophoretic comparison of metastatic and non-metastatic human breast tumors using in vitrocultured epithelial cells derived from the cancer tissues
J Vydra, I Selicharová, K Smutná, M Šanda, E Matoušková, E Buršíková, M Prchalová, Z Velenská, D Coufal, J Jiráček
BMC Cancer 2008

← Previous 1 2 … 10 11 12 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts